FEV1 decline is accelerated in only a minority of patients with COPD: a factorial analysis of longitudinal data
P. Burgel (Paris, France), T. Perez (Lille, France), G. Deslée (Reims, France), M. Zysman (Bordeaux, France), O. Le Rouzic (Lille, France), P. Chanez (Marseille, France), G. Jébrak (Paris, France), I. Court-Fortune (Saint Etienne, France), G. Brinchault (Rennes, France), P. Nesme-Meyer (Lyon, France), A. Guillaumot (Nancy, France), B. Ribeiro-Baptista (Créteil, France), E. Ouaalaya (Paris, France), J. Paillasseur (Paris, France), N. Roche (Paris, France)
Source: International Congress 2022 – COPD: from biomarkers to phenotypes and severity
Session: COPD: from biomarkers to phenotypes and severity
Session type: Thematic Poster
Number: 3890
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Burgel (Paris, France), T. Perez (Lille, France), G. Deslée (Reims, France), M. Zysman (Bordeaux, France), O. Le Rouzic (Lille, France), P. Chanez (Marseille, France), G. Jébrak (Paris, France), I. Court-Fortune (Saint Etienne, France), G. Brinchault (Rennes, France), P. Nesme-Meyer (Lyon, France), A. Guillaumot (Nancy, France), B. Ribeiro-Baptista (Créteil, France), E. Ouaalaya (Paris, France), J. Paillasseur (Paris, France), N. Roche (Paris, France). FEV1 decline is accelerated in only a minority of patients with COPD: a factorial analysis of longitudinal data. 3890
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|